PNPO and ovarian carcinoma: Pyridoxine 5′-phosphate oxidase (PNPO), a converting enzyme for the active form of vitamin B6, pyridoxal 5′-phosphate (PLP), is overexpressed in human ovarian cancer, and PNPO suppression can inhibit proliferation, migration, invasion and colony formation of breast cancer cells [96].